Haemonetics is a healthcare company. Co.'s segments are: Plasma, which provides plasma collection devices and disposables, plasma donor management software and anticoagulant and saline sold to plasma customers; Blood Center, which provides blood collection and processing devices and disposables for red cells, platelets and whole blood; and Hospital, which is comprised of Hemostasis Management, Cell Salvage, Transfusion Management and Vascular Closure products, including devices and methodologies for measuring coagulation characteristics of blood, surgical blood salvage systems, blood cell processing systems and disposables, blood transfusion management software and vascular closure devices. The HAE stock yearly return is shown above.
The yearly return on the HAE stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2019 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the HAE annual return calculation with any dividends reinvested as applicable (on ex-dates).
|